nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—MUT—parathyroid gland—thymus cancer	0.0602	0.0923	CbGeAlD
Hydroxocobalamin—Redness—Octreotide—thymus cancer	0.0217	0.0798	CcSEcCtD
Hydroxocobalamin—MMAA—hematopoietic system—thymus cancer	0.0202	0.031	CbGeAlD
Hydroxocobalamin—CUBN—epithelium—thymus cancer	0.0195	0.0299	CbGeAlD
Hydroxocobalamin—TCN1—hematopoietic system—thymus cancer	0.0192	0.0295	CbGeAlD
Hydroxocobalamin—MMAB—hematopoietic system—thymus cancer	0.0189	0.029	CbGeAlD
Hydroxocobalamin—MUT—neck—thymus cancer	0.0183	0.028	CbGeAlD
Hydroxocobalamin—MMACHC—lung—thymus cancer	0.0179	0.0274	CbGeAlD
Hydroxocobalamin—CASP9—hematopoietic system—thymus cancer	0.0177	0.0271	CbGeAlD
Hydroxocobalamin—TCN2—hematopoietic system—thymus cancer	0.0173	0.0265	CbGeAlD
Hydroxocobalamin—Extravasation—Octreotide—thymus cancer	0.0168	0.0618	CcSEcCtD
Hydroxocobalamin—CUBN—pituitary gland—thymus cancer	0.0158	0.0243	CbGeAlD
Hydroxocobalamin—AMN—lung—thymus cancer	0.0147	0.0226	CbGeAlD
Hydroxocobalamin—Injection site reaction—Octreotide—thymus cancer	0.0145	0.0536	CcSEcCtD
Hydroxocobalamin—MMAB—pituitary gland—thymus cancer	0.0141	0.0215	CbGeAlD
Hydroxocobalamin—CUBN—thyroid gland—thymus cancer	0.0137	0.0209	CbGeAlD
Hydroxocobalamin—MUT—hematopoietic system—thymus cancer	0.0136	0.0208	CbGeAlD
Hydroxocobalamin—MMAA—thyroid gland—thymus cancer	0.0129	0.0198	CbGeAlD
Hydroxocobalamin—TCN2—pituitary gland—thymus cancer	0.0128	0.0196	CbGeAlD
Hydroxocobalamin—CASP9—lymphoid tissue—thymus cancer	0.0125	0.0191	CbGeAlD
Hydroxocobalamin—TCN1—bone marrow—thymus cancer	0.0123	0.0189	CbGeAlD
Hydroxocobalamin—Phlebitis—Octreotide—thymus cancer	0.0123	0.0454	CcSEcCtD
Hydroxocobalamin—TCN1—thyroid gland—thymus cancer	0.0123	0.0188	CbGeAlD
Hydroxocobalamin—MTRR—hematopoietic system—thymus cancer	0.0122	0.0187	CbGeAlD
Hydroxocobalamin—TCN2—lymphoid tissue—thymus cancer	0.0122	0.0186	CbGeAlD
Hydroxocobalamin—MMAB—thyroid gland—thymus cancer	0.0121	0.0186	CbGeAlD
Hydroxocobalamin—MMAA—lung—thymus cancer	0.0117	0.018	CbGeAlD
Hydroxocobalamin—Cardiac failure congestive—Octreotide—thymus cancer	0.0117	0.0431	CcSEcCtD
Hydroxocobalamin—Hot flush—Octreotide—thymus cancer	0.0114	0.0418	CcSEcCtD
Hydroxocobalamin—CASP9—thyroid gland—thymus cancer	0.0113	0.0173	CbGeAlD
Hydroxocobalamin—Menopausal symptoms—Octreotide—thymus cancer	0.0113	0.0414	CcSEcCtD
Hydroxocobalamin—TCN1—lung—thymus cancer	0.0112	0.0171	CbGeAlD
Hydroxocobalamin—TCN2—thyroid gland—thymus cancer	0.011	0.0169	CbGeAlD
Hydroxocobalamin—MMAB—lung—thymus cancer	0.011	0.0169	CbGeAlD
Hydroxocobalamin—MTR—hematopoietic system—thymus cancer	0.0106	0.0163	CbGeAlD
Hydroxocobalamin—MUT—cardiac atrium—thymus cancer	0.0103	0.0158	CbGeAlD
Hydroxocobalamin—CASP9—lung—thymus cancer	0.0103	0.0158	CbGeAlD
Hydroxocobalamin—AMN—lymph node—thymus cancer	0.0101	0.0154	CbGeAlD
Hydroxocobalamin—MUT—pituitary gland—thymus cancer	0.0101	0.0154	CbGeAlD
Hydroxocobalamin—TCN2—lung—thymus cancer	0.01	0.0154	CbGeAlD
Hydroxocobalamin—MTRR—cardiac atrium—thymus cancer	0.00927	0.0142	CbGeAlD
Hydroxocobalamin—MTRR—pituitary gland—thymus cancer	0.00905	0.0139	CbGeAlD
Hydroxocobalamin—Abdominal discomfort—Octreotide—thymus cancer	0.0088	0.0324	CcSEcCtD
Hydroxocobalamin—MUT—bone marrow—thymus cancer	0.00871	0.0133	CbGeAlD
Hydroxocobalamin—MUT—thyroid gland—thymus cancer	0.00869	0.0133	CbGeAlD
Hydroxocobalamin—CUBN—lymph node—thymus cancer	0.00848	0.013	CbGeAlD
Hydroxocobalamin—MTR—cardiac atrium—thymus cancer	0.00808	0.0124	CbGeAlD
Hydroxocobalamin—MMAA—lymph node—thymus cancer	0.00802	0.0123	CbGeAlD
Hydroxocobalamin—MTR—pituitary gland—thymus cancer	0.0079	0.0121	CbGeAlD
Hydroxocobalamin—MUT—lung—thymus cancer	0.00789	0.0121	CbGeAlD
Hydroxocobalamin—MTRR—bone marrow—thymus cancer	0.00783	0.012	CbGeAlD
Hydroxocobalamin—MTRR—thyroid gland—thymus cancer	0.00781	0.012	CbGeAlD
Hydroxocobalamin—MMAB—lymph node—thymus cancer	0.00752	0.0115	CbGeAlD
Hydroxocobalamin—Oedema peripheral—Octreotide—thymus cancer	0.00724	0.0267	CcSEcCtD
Hydroxocobalamin—MTRR—lung—thymus cancer	0.00709	0.0109	CbGeAlD
Hydroxocobalamin—CASP9—lymph node—thymus cancer	0.00703	0.0108	CbGeAlD
Hydroxocobalamin—CASP9—NOD1/2 Signaling Pathway—CYLD—thymus cancer	0.00688	0.0907	CbGpPWpGaD
Hydroxocobalamin—TCN2—lymph node—thymus cancer	0.00686	0.0105	CbGeAlD
Hydroxocobalamin—MTR—bone marrow—thymus cancer	0.00683	0.0105	CbGeAlD
Hydroxocobalamin—Cardiac disorder—Octreotide—thymus cancer	0.00682	0.0251	CcSEcCtD
Hydroxocobalamin—MTR—thyroid gland—thymus cancer	0.00681	0.0104	CbGeAlD
Hydroxocobalamin—Immune system disorder—Octreotide—thymus cancer	0.00664	0.0244	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Octreotide—thymus cancer	0.00656	0.0242	CcSEcCtD
Hydroxocobalamin—Mental disorder—Octreotide—thymus cancer	0.00644	0.0237	CcSEcCtD
Hydroxocobalamin—Erythema—Octreotide—thymus cancer	0.0064	0.0236	CcSEcCtD
Hydroxocobalamin—MTR—lung—thymus cancer	0.00618	0.00948	CbGeAlD
Hydroxocobalamin—Ill-defined disorder—Octreotide—thymus cancer	0.00593	0.0219	CcSEcCtD
Hydroxocobalamin—Agitation—Octreotide—thymus cancer	0.00588	0.0216	CcSEcCtD
Hydroxocobalamin—Malaise—Octreotide—thymus cancer	0.00577	0.0212	CcSEcCtD
Hydroxocobalamin—Chest pain—Octreotide—thymus cancer	0.00544	0.0201	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00541	0.0199	CcSEcCtD
Hydroxocobalamin—MUT—lymph node—thymus cancer	0.0054	0.00827	CbGeAlD
Hydroxocobalamin—Discomfort—Octreotide—thymus cancer	0.00538	0.0198	CcSEcCtD
Hydroxocobalamin—Oedema—Octreotide—thymus cancer	0.00522	0.0192	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Octreotide—thymus cancer	0.00522	0.0192	CcSEcCtD
Hydroxocobalamin—Infection—Octreotide—thymus cancer	0.00519	0.0191	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Octreotide—thymus cancer	0.00512	0.0189	CcSEcCtD
Hydroxocobalamin—Tachycardia—Octreotide—thymus cancer	0.00509	0.0188	CcSEcCtD
Hydroxocobalamin—Skin disorder—Octreotide—thymus cancer	0.00507	0.0187	CcSEcCtD
Hydroxocobalamin—MTRR—lymph node—thymus cancer	0.00485	0.00743	CbGeAlD
Hydroxocobalamin—CASP9—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CYLD—thymus cancer	0.0047	0.0619	CbGpPWpGaD
Hydroxocobalamin—Dyspnoea—Octreotide—thymus cancer	0.00465	0.0171	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Octreotide—thymus cancer	0.00459	0.0169	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Octreotide—thymus cancer	0.00451	0.0166	CcSEcCtD
Hydroxocobalamin—Pain—Octreotide—thymus cancer	0.00446	0.0164	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Octreotide—thymus cancer	0.0043	0.0158	CcSEcCtD
Hydroxocobalamin—MTR—lymph node—thymus cancer	0.00423	0.00648	CbGeAlD
Hydroxocobalamin—Urticaria—Octreotide—thymus cancer	0.00415	0.0153	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Octreotide—thymus cancer	0.00413	0.0152	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Octreotide—thymus cancer	0.00385	0.0142	CcSEcCtD
Hydroxocobalamin—Pruritus—Octreotide—thymus cancer	0.00369	0.0136	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Octreotide—thymus cancer	0.00357	0.0132	CcSEcCtD
Hydroxocobalamin—Dizziness—Octreotide—thymus cancer	0.00345	0.0127	CcSEcCtD
Hydroxocobalamin—Rash—Octreotide—thymus cancer	0.00329	0.0121	CcSEcCtD
Hydroxocobalamin—Dermatitis—Octreotide—thymus cancer	0.00329	0.0121	CcSEcCtD
Hydroxocobalamin—Headache—Octreotide—thymus cancer	0.00327	0.012	CcSEcCtD
Hydroxocobalamin—Nausea—Octreotide—thymus cancer	0.0031	0.0114	CcSEcCtD
Hydroxocobalamin—CASP9—AKT phosphorylates targets in the cytosol—AKT1—thymus cancer	0.00193	0.0254	CbGpPWpGaD
Hydroxocobalamin—MTRR—Folate Metabolism—IL2—thymus cancer	0.00158	0.0208	CbGpPWpGaD
Hydroxocobalamin—MTR—Folate Metabolism—IL2—thymus cancer	0.00129	0.017	CbGpPWpGaD
Hydroxocobalamin—CASP9—Constitutive PI3K/AKT Signaling in Cancer—KIT—thymus cancer	0.00112	0.0147	CbGpPWpGaD
Hydroxocobalamin—MTRR—Folate Metabolism—TP53—thymus cancer	0.00102	0.0134	CbGpPWpGaD
Hydroxocobalamin—CASP9—PI-3K cascade—KIT—thymus cancer	0.00101	0.0132	CbGpPWpGaD
Hydroxocobalamin—CASP9—PI3K/AKT activation—KIT—thymus cancer	0.000981	0.0129	CbGpPWpGaD
Hydroxocobalamin—CASP9—GAB1 signalosome—KIT—thymus cancer	0.000974	0.0128	CbGpPWpGaD
Hydroxocobalamin—CASP9—Amyotrophic lateral sclerosis (ALS)—TP53—thymus cancer	0.000969	0.0128	CbGpPWpGaD
Hydroxocobalamin—CASP9—Intrinsic Pathway for Apoptosis—TP53—thymus cancer	0.000969	0.0128	CbGpPWpGaD
Hydroxocobalamin—CASP9—Role of LAT2/NTAL/LAB on calcium mobilization—KIT—thymus cancer	0.000951	0.0125	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—CDKN2A—thymus cancer	0.000924	0.0122	CbGpPWpGaD
Hydroxocobalamin—CASP9—Class I PI3K signaling events mediated by Akt—AKT1—thymus cancer	0.000874	0.0115	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis Modulation and Signaling—CDKN2A—thymus cancer	0.000866	0.0114	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Cancer Pathway—TP53—thymus cancer	0.000862	0.0114	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—MAML2—thymus cancer	0.000843	0.0111	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—IL2—thymus cancer	0.000841	0.0111	CbGpPWpGaD
Hydroxocobalamin—MTR—Folate Metabolism—TP53—thymus cancer	0.000828	0.0109	CbGpPWpGaD
Hydroxocobalamin—CASP9—Intrinsic Pathway for Apoptosis—AKT1—thymus cancer	0.000819	0.0108	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—MAML2—thymus cancer	0.000771	0.0102	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—MAML2—thymus cancer	0.000771	0.0102	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—KIT—thymus cancer	0.000752	0.0099	CbGpPWpGaD
Hydroxocobalamin—CASP9—Corticotropin-releasing hormone—IL2—thymus cancer	0.000744	0.00981	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Cancer Pathway—AKT1—thymus cancer	0.000728	0.00959	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—KIT—thymus cancer	0.000719	0.00948	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—MAML2—thymus cancer	0.000717	0.00945	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—KIT—thymus cancer	0.000708	0.00933	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—KIT—thymus cancer	0.000676	0.00891	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—KIT—thymus cancer	0.000673	0.00886	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—KIT—thymus cancer	0.000669	0.00882	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—KIT—thymus cancer	0.000666	0.00878	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CYLD—thymus cancer	0.000664	0.00875	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—KIT—thymus cancer	0.000656	0.00865	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—MAML2—thymus cancer	0.000639	0.00842	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—MAML2—thymus cancer	0.000639	0.00842	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—KIT—thymus cancer	0.000627	0.00826	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—KIT—thymus cancer	0.000627	0.00826	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—KIT—thymus cancer	0.000627	0.00826	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—KIT—thymus cancer	0.000621	0.00818	CbGpPWpGaD
Hydroxocobalamin—CASP9—Rac1/Pak1/p38/MMP-2 pathway—TP53—thymus cancer	0.000616	0.00812	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—KIT—thymus cancer	0.000615	0.00811	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—KIT—thymus cancer	0.000613	0.00807	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MAML2—thymus cancer	0.00061	0.00803	CbGpPWpGaD
Hydroxocobalamin—CASP9—DNA Damage Response—TP53—thymus cancer	0.000609	0.00802	CbGpPWpGaD
Hydroxocobalamin—CASP9—p75(NTR)-mediated signaling—TP53—thymus cancer	0.000602	0.00793	CbGpPWpGaD
Hydroxocobalamin—CASP9—Caspase Cascade in Apoptosis—AKT1—thymus cancer	0.000592	0.0078	CbGpPWpGaD
Hydroxocobalamin—CASP9—miRNA Regulation of DNA Damage Response—TP53—thymus cancer	0.000588	0.00775	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—KIT—thymus cancer	0.00058	0.00764	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MAML2—thymus cancer	0.000563	0.00741	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—KIT—thymus cancer	0.000555	0.00731	CbGpPWpGaD
Hydroxocobalamin—CASP9—Alzheimers Disease—TP53—thymus cancer	0.00054	0.00711	CbGpPWpGaD
Hydroxocobalamin—CASP9—AGE/RAGE pathway—AKT1—thymus cancer	0.000526	0.00694	CbGpPWpGaD
Hydroxocobalamin—CASP9—Rac1/Pak1/p38/MMP-2 pathway—AKT1—thymus cancer	0.00052	0.00685	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—TP53—thymus cancer	0.000514	0.00677	CbGpPWpGaD
Hydroxocobalamin—CASP9—p75(NTR)-mediated signaling—AKT1—thymus cancer	0.000508	0.00669	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis Modulation and Signaling—TP53—thymus cancer	0.000482	0.00635	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MAML2—thymus cancer	0.000462	0.00609	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—AKT1—thymus cancer	0.000434	0.00572	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—KIT—thymus cancer	0.000427	0.00562	CbGpPWpGaD
Hydroxocobalamin—CASP9—Constitutive PI3K/AKT Signaling in Cancer—AKT1—thymus cancer	0.000426	0.00561	CbGpPWpGaD
Hydroxocobalamin—CASP9—TNF alpha Signaling Pathway—AKT1—thymus cancer	0.000404	0.00532	CbGpPWpGaD
Hydroxocobalamin—CASP9—Corticotropin-releasing hormone—AKT1—thymus cancer	0.000404	0.00532	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—KIT—thymus cancer	0.000389	0.00513	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CYLD—thymus cancer	0.000387	0.00509	CbGpPWpGaD
Hydroxocobalamin—CASP9—PI-3K cascade—AKT1—thymus cancer	0.000384	0.00506	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MAML2—thymus cancer	0.000377	0.00496	CbGpPWpGaD
Hydroxocobalamin—CASP9—PI3K/AKT activation—AKT1—thymus cancer	0.000375	0.00494	CbGpPWpGaD
Hydroxocobalamin—CASP9—GAB1 signalosome—AKT1—thymus cancer	0.000372	0.0049	CbGpPWpGaD
Hydroxocobalamin—CASP9—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—thymus cancer	0.000363	0.00478	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—KIT—thymus cancer	0.000356	0.00469	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—KIT—thymus cancer	0.000356	0.00469	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—KIT—thymus cancer	0.000331	0.00436	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—TP53—thymus cancer	0.000321	0.00424	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—TP53—thymus cancer	0.000315	0.00415	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CD8A—thymus cancer	0.000311	0.0041	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—CD4—thymus cancer	0.000298	0.00392	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—TP53—thymus cancer	0.000295	0.00389	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—KIT—thymus cancer	0.000295	0.00389	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—KIT—thymus cancer	0.000295	0.00389	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—AKT1—thymus cancer	0.000287	0.00378	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MAML2—thymus cancer	0.000284	0.00374	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—KIT—thymus cancer	0.000281	0.00371	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—AKT1—thymus cancer	0.000274	0.00362	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—CD4—thymus cancer	0.000272	0.00359	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—CD4—thymus cancer	0.000272	0.00359	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—AKT1—thymus cancer	0.000271	0.00358	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—AKT1—thymus cancer	0.00027	0.00356	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	0.000266	0.00351	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—AKT1—thymus cancer	0.000266	0.0035	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—KIT—thymus cancer	0.00026	0.00342	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—AKT1—thymus cancer	0.000258	0.0034	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—AKT1—thymus cancer	0.000257	0.00338	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—AKT1—thymus cancer	0.000255	0.00337	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—AKT1—thymus cancer	0.000254	0.00335	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—CD4—thymus cancer	0.000253	0.00334	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thymus cancer	0.00025	0.0033	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—AKT1—thymus cancer	0.000249	0.00328	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—KIT—thymus cancer	0.000243	0.00321	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—AKT1—thymus cancer	0.000239	0.00315	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	0.000239	0.00315	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—AKT1—thymus cancer	0.000239	0.00315	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—AKT1—thymus cancer	0.000237	0.00312	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—AKT1—thymus cancer	0.000235	0.00309	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—AKT1—thymus cancer	0.000234	0.00308	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—KIT—thymus cancer	0.000234	0.00308	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—CD4—thymus cancer	0.000226	0.00297	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—CD4—thymus cancer	0.000226	0.00297	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	0.000225	0.00296	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—AKT1—thymus cancer	0.000221	0.00292	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—CD4—thymus cancer	0.000215	0.00284	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—KIT—thymus cancer	0.000213	0.00281	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	0.000212	0.00279	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—CD4—thymus cancer	0.000199	0.00262	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MAML2—thymus cancer	0.000199	0.00262	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD8A—thymus cancer	0.000189	0.00249	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CD4—thymus cancer	0.000186	0.00245	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CD4—thymus cancer	0.000179	0.00236	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—KIT—thymus cancer	0.000174	0.00229	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CD4—thymus cancer	0.000163	0.00215	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—AKT1—thymus cancer	0.000163	0.00215	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—AKT1—thymus cancer	0.000149	0.00196	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KIT—thymus cancer	0.000142	0.00187	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—AKT1—thymus cancer	0.000136	0.00179	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—AKT1—thymus cancer	0.000136	0.00179	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CD4—thymus cancer	0.000133	0.00175	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—KIT—thymus cancer	0.000131	0.00173	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—AKT1—thymus cancer	0.000126	0.00166	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—AKT1—thymus cancer	0.000124	0.00164	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—AKT1—thymus cancer	0.000114	0.0015	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—AKT1—thymus cancer	0.000114	0.0015	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—AKT1—thymus cancer	0.000113	0.00148	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—AKT1—thymus cancer	0.000113	0.00148	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD4—thymus cancer	0.000108	0.00143	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—AKT1—thymus cancer	0.000107	0.00142	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—AKT1—thymus cancer	0.000106	0.00139	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CD4—thymus cancer	0.0001	0.00132	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL2—thymus cancer	9.98e-05	0.00131	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—AKT1—thymus cancer	9.91e-05	0.00131	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—AKT1—thymus cancer	9.43e-05	0.00124	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—AKT1—thymus cancer	9.43e-05	0.00124	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—AKT1—thymus cancer	9.29e-05	0.00122	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KIT—thymus cancer	9.17e-05	0.00121	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—AKT1—thymus cancer	8.99e-05	0.00119	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—AKT1—thymus cancer	8.92e-05	0.00118	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—AKT1—thymus cancer	8.3e-05	0.00109	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—AKT1—thymus cancer	8.14e-05	0.00107	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—AKT1—thymus cancer	6.82e-05	0.000898	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—AKT1—thymus cancer	6.64e-05	0.000874	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL2—thymus cancer	6.45e-05	0.00085	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—AKT1—thymus cancer	5.56e-05	0.000732	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—AKT1—thymus cancer	5.41e-05	0.000713	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—AKT1—thymus cancer	5e-05	0.000658	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TP53—thymus cancer	4.14e-05	0.000546	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKT1—thymus cancer	3.5e-05	0.000461	CbGpPWpGaD
